US Broker Ratings

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Understanding the Dynamics of a $6.96 Billion Biotech

Cidara Therapeutics, Inc. (NASDAQ: CDTX) is a promising player in the biotechnology sector, specializing in developing targeted therapies for serious diseases, including cancer and invasive fungal infections. With a market..

Compass Therapeutics, Inc. (CMPX) Stock Analysis: Uncovering a 114.79% Potential Upside in Biotechnology

Investors with an eye on the burgeoning biotechnology sector may find Compass Therapeutics, Inc. (NASDAQ: CMPX) to be an intriguing prospect. The Boston-based clinical-stage biopharmaceutical company, with a market capitalization..

ReposiTrak, Inc. (TRAK) Stock Analysis: Is the Software Innovator a Hidden Gem in the Tech Sector?

ReposiTrak, Inc. (NASDAQ: TRAK), a burgeoning player in the Software – Application industry, is attracting attention within the tech sector for its unique business model and potential growth, despite limited..

Sanara MedTech Inc. (SMTI) Stock Analysis: A Potential 87% Upside in Healthcare Innovation

Sanara MedTech Inc. (NASDAQ: SMTI) offers a compelling opportunity for investors seeking exposure to the healthcare sector, particularly in the realm of medical instruments and supplies. Based in Fort Worth,..

Asure Software Inc (ASUR) Stock Analysis: 34.78% Potential Upside Grabs Investor Attention

Asure Software Inc (ASUR), a key player in the Technology sector under the Software – Application industry, has been capturing investor interest with its compelling growth potential and robust analyst..

Domo, Inc. (DOMO) Stock Analysis: Exploring a 162% Potential Upside with Strategic Data Solutions

For investors seeking opportunities in the technology sector, Domo, Inc. (NASDAQ: DOMO) presents an intriguing case with a potential upside of 162.32%, as suggested by its average target price of..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring a 33% Potential Upside for Investors

Fair Isaac Corporation (NYSE: FICO), a prominent entity in the technology sector, has been making waves with its sophisticated analytics software solutions. From its headquarters in Bozeman, Montana, FICO has..

Applovin Corporation (APP) Stock Report: Strong Buy Ratings and 36% Upside Potential

Applovin Corporation (NYSE: APP), a titan in the Communication Services sector, is capturing investor attention with its robust market presence and promising growth trajectory. With a market capitalization of $183.45..

Porch Group, Inc. (PRCH) Stock Analysis: Exploring a Potential 118% Upside for Investors

Porch Group, Inc. (NASDAQ: PRCH) stands out as a compelling player in the Technology sector, specifically within the Software – Application industry. With its operations rooted in the United States,..

Asana, Inc. (ASAN) Stock Analysis: Can This Work Management Platform Unlock a 43% Upside?

Asana, Inc. (NYSE: ASAN), a prominent player in the technology sector’s software application industry, offers a compelling opportunity for investors looking to tap into the burgeoning work management software market...

Pacific Biosciences of California (PACB) Stock Analysis: Navigating Growth Potential Amidst Market Challenges

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a key player in the healthcare sector, operates within the medical devices industry, specializing in advanced sequencing technologies. With a market capitalization of..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech with 355% Potential Upside

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a burgeoning player in the biotechnology sector, is capturing investor attention with its cutting-edge developments in mRNA-based therapeutics. Based in San Diego, California, this..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating Volatility with a Market Cap of $8.72 Million

NetClass Technology Inc (NTCL) is a software application company that operates within the dynamic technology sector, focusing on online professional education platforms. Despite being incorporated only in 2022, the company..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Biotech Innovator with 44% Potential Upside

Investors with an eye on the biotechnology sector might find CytomX Therapeutics, Inc. (NASDAQ: CTMX) an intriguing opportunity. With a market capitalization just shy of $1 billion, this healthcare innovator..

Shopify Inc. (SHOP) Stock Analysis: Is a 29% Potential Upside Worth the Investment?

Shopify Inc. (NYSE: SHOP), a titan in the e-commerce technology landscape, is generating buzz among investors with a substantial potential upside of 29.20%. As the company continues to redefine the..

Varex Imaging Corporation (VREX) Stock Analysis: Uncovering a 23% Upside Potential in the Medical Devices Sector

Varex Imaging Corporation (NASDAQ: VREX) stands out in the healthcare sector as a key player in the medical devices industry, with a market capitalization of $586.03 million. Specializing in the..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Uncovering a 104% Potential Upside in the Medical Device Sector

SANUWAVE Health, Inc. (SNWV), a burgeoning player in the healthcare sector, is making waves in the medical device industry with its innovative approach to regenerative medicine. Based in Eden Prairie,..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Uncovering a Potential 269.75% Upside in Biotech Innovation

Gossamer Bio, Inc. (NASDAQ: GOSS) has captured the attention of investors with its ambitious focus on developing groundbreaking treatments in the biotechnology sector. Headquartered in San Diego, California, Gossamer Bio..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Exploring a 113% Potential Upside in Biotech Innovation

Tvardi Therapeutics, Inc. (NASDAQ: TVRD), a clinical-stage biopharmaceutical company based in Sugar Land, Texas, is making waves in the biotechnology industry with its promising pipeline of therapies targeting STAT3 for..

Alumis Inc. (ALMS) Stock Analysis: A Biotech Contender with a 34.43% Potential Upside

Alumis Inc. (NASDAQ: ALMS), a burgeoning player in the biotechnology sector, is grabbing investor attention with its promising pipeline focused on autoimmune disorders. Based in South San Francisco, California, Alumis..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds